RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor

Business

RIS Rx Welcomes Industry Pioneer Tom Doyle as Senior Advisor

2026-04-23 22:30 Last Updated At：22:40

IRVINE, Calif.--(BUSINESS WIRE)--Apr 23, 2026--

RIS Rx, the healthcare technology company delivering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, today announced that Tom Doyle has joined the organization as Senior Advisor. Doyle, a widely respected executive with decades of leadership across pharmaceutical distribution, services, and outsourced commercialization, will provide strategic guidance as RIS Rx continues to expand its footprint across the industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260423411186/en/

Tom brings an extraordinary track record to his new role. He spent several years at Cencora Biopharma Services in senior executive leadership, including serving as SVP and Chief Customer Officer. Throughout his tenure, he led teams focused on integrating the full spectrum of Cencora's global capabilities to enhance patient outcomes. Prior to Cencora, he served as SVP of Program Leadership at EVERSANA, spearheading the launch of outsourced commercialization services and overseeing a team of Chief Commercial Officers. Earlier, as EVP of Commercial Solutions at H.D. Smith, he led the company's expansion into 3PL, specialty distribution, and patient services - including the acquisition of Triplefin, which accelerated growth in the patient support space.

"Tom is one of the most respected minds in this industry," said Gerard Rivera, Co-founder and CEO of RIS Rx. "Stephen and I have admired his work for more than a decade. He has an extraordinary ability to recognize problems worth solving and people committed to solving them. Having him as a strategic advisor as we continue to grow our GTN Revenue Protection capabilities is an incredible addition for our team and for our clients."

Stephen Hom, Co-founder, EVP and COO of RIS Rx, echoed the sentiment: "Tom has always pushed us to think bigger and act with more conviction. He understands the complexity of this industry - the GTN leakage problem, the blind spots manufacturers face, the gap between what they invest in patient affordability and what patients actually receive. His perspective at this stage of RIS Rx's growth is exactly what we need."

For Doyle, the decision was clear. "Seldom in your career do you encounter a business with a 95 Net Promoter Score," said Tom Doyle, Senior Advisor at RIS Rx. "That number reflects something real - a team that is genuinely solving problems and doing it in a way that earns trust. I've watched Gerard and Stephen build RIS Rx from the outside for years. Being part of what RIS Rx is doing in GTN Revenue Protection, at this moment in the industry, is exactly where I want to be."

Doyle's arrival comes as RIS Rx continues to gain momentum across the pharmaceutical industry, having protected more than $1 billion in annual revenue for its clients through proprietary real-time analytics, pharmacist-led expertise, and patient segmentation capabilities that prevent GTN leakage before it occurs. His appointment underscores the company's commitment to building the most experienced advisory team in the GTN Revenue Protection space.

Tom will be on the ground with the RIS Rx team at Asembia AXS26 in Las Vegas over the coming week.

About RIS Rx

RIS Rx is a healthcare technology company delivering real-time gross-to-net (GTN) revenue protection for the world’s leading pharmaceutical manufacturers. Through proprietary software, real-time analytics and pharmacist-led expertise, RIS Rx helps clients optimize operations, eliminate leakage and ensure that financial assistance reaches the patients who need it most. The company has protected more than $1 billion in annual revenue for its customers. Founded in 2020 and headquartered in Irvine, California, RIS Rx serves leading pharmaceutical manufacturers across a growing portfolio of drug brands. Learn more at www.RISRx.com.

US stocks edge back from their records as oil prices swing higher

NEW YORK (AP) — The U.S. stock market is edging back from its all-time high Thursday following mixed profit reports from Tesla and other big companies. Oil prices, meanwhile, are swinging higher on continued uncertainty about what will happen next in the war with Iran.

The S&P 500 slipped 0.1% following a big rally that erased all its losses because of the war and then carried it to records. The Dow Jones Industrial Average was down 71 points, or 0.1%, as of 10:15 a.m. Eastern, and the Nasdaq composite was 0.5% lower after setting its own record.

Tesla dragged on the market and fell 4.3% even though it reported better results for the latest quarter than analysts expected. Investors may be focusing instead on Tesla’s increased forecast for spending this year, as it builds factories to make robots and other products.

“You should expect to see a very significant increase in capital expenditures,” Elon Musk told investors late Wednesday, “but I think well justified for a substantially increased future revenue stream.”

ServiceNow dropped even more, 16.2%, even though its results for the latest quarter matched analysts’ expectations. The company has been under pressure, along with much of the broad software industry, because of worries that rivals powered by artificial-intelligence technology could undercut its business.

Analysts said investors may have also been underwhelmed by its forecast for a declaration in growth for an important measure of revenue.

Texas Instruments helped limit Wall Street's losses after breezing past analysts' expectations for profit in the latest quarter. CEO Haviv Ilan said the semiconductor company is benefiting from growth led by industrial and data center customers, and it gave forecasts for profit and revenue in the spring that cleared analysts' estimates.

The 16.6% leap for Texas Instrument's stock was the strongest single force pushing upward on the S&P 500.

In the oil market, prices swung higher as uncertainty continues about what will happen with the Strait of Hormuz. A ceasefire is still in place between the United States and Iran, but oil tankers aren’t able to get through the narrow waterway off Iran's coast to exit the Persian Gulf and reach customers.

The U.S. military on Thursday seized another tanker associated with the smuggling of Iranian oil, ratcheting up the standoff a day after Iran’s paramilitary Revolutionary Guards took control of two vessels in the strait. President Donald Trump also said Thursday he ordered the U.S. military to “shoot and kill” small Iranian boats that deploy mines to gum up traffic in the strait.

The price for a barrel of Brent crude, the international standard, rose 1% to $102.97 after bouncing between roughly $101 and $106 overnight. It’s unclear whether U.S.-Iran peace talks, previously hosted by Pakistan, would resume anytime soon.

More expensive oil has hurt airlines in particular because of the industry's already big fuel bills, and stocks diverged in the industry following the latest profit reports.

American Airlines Group rose 4% after reporting better profit and revenue for the latest quarter than analysts expected. Even though winter storms hurt its revenue during the first three months of the year, American said demand was strong for flights, and it saw the nine best weeks for revenue intake in its 100-year history.

Southwest Airlines, though, lost 2.2% after reporting weaker quarterly results than analysts expected. It said it would not give an updated forecast for profit this year because of “the ongoing macroeconomic uncertainty.”

Also on the losing end of Wall Street was IBM, which sank 9.7% despite reporting better profit and revenue for the latest quarter than expected. Analysts said investors were focusing on some potentially discouraging numbers underneath the surface, including decelerating growth in trends for its software business.

In stock markets abroad, indexes fell across much of Europe and Asia. Hong Kong’s Hang Seng fell 0.9%, and Japan’s Nikkei 225 sank 0.7% for two of the bigger losses.

South Korea’s Kospi climbed 0.9% after the government reported better-than-expected economic growth for the start of the year, boosted by strong exports, particularly of computer chips used in the AI boom. Semiconductor supplier SK Hynix said its revenue for the latest quarter jumped more than analysts expected largely because of AI-related demand.

In the bond market, the yield on the 10-year Treasury edged down to 4.29% from 4.30% late Wednesday.

A report in the morning said slightly more U.S. workers applied for unemployment benefits last week, but the number is still at a historically healthy level. A separate, preliminary report on U.S. business output from S&P Global also suggested growth is improving a bit from its near-stagnation seen in March.

AP Business Writers Chan Ho-him and Matt Ott contributed to this report.